Skip to content

Study · Not a test of the peptide alone · 1990

3 results

[Effectiveness of administration of thymalin in the complex treatment of pulmonary tuberculosis].

Kogosova LS, Chernushenko EF, Il'nitskiĭ IG, Goncharova SI, Markov AE, Kuchugura-Kucherenko LV

Problemy tuberkuleza1 Jan 1990

PMID2080155 (opens in a new tab)PepBankPUB-02080155

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In patients with destructive pulmonary tuberculosis, differential thymalin administration with chemotherapy shortened hospital stay.

    In plain wordsIn patients with destructive lung tuberculosis, the thymalin and chemotherapy regimen shortened hospital stay.

    Peptide
    Thymalin
    Outcome
    DecreaseHospital stay
    Study

    n = 60

    Outcome group
    Intensive care and hospital outcomes · Respiratory

    Source sentences

    Summary
    A ++clinico-roentgenologic and immunologic evaluation of in-patient treatment of 60 cases demonstrated that a differential administration of thymalin in combination with chemotherapeutic drugs greatly shortened the stay at a hospital and increased the efficacy of treatment.
    1 context sentence
    Summary · context
    The criteria of differential administration of thymalin in the combined management of patients with destructive pulmonary tuberculosis were defined on the basis of immunologic studies.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In patients with destructive pulmonary tuberculosis, differential thymalin administration with chemotherapy increased treatment efficacy.

    In plain wordsIn patients with destructive lung tuberculosis, the thymalin and chemotherapy regimen increased treatment effectiveness.

    Peptide
    Thymalin
    Outcome
    IncreaseTreatment efficacy
    Study

    n = 60

    Outcome group
    Infection and antimicrobial activity · Respiratory

    Source sentences

    Summary
    A ++clinico-roentgenologic and immunologic evaluation of in-patient treatment of 60 cases demonstrated that a differential administration of thymalin in combination with chemotherapeutic drugs greatly shortened the stay at a hospital and increased the efficacy of treatment.
    1 context sentence
    Summary · context
    The criteria of differential administration of thymalin in the combined management of patients with destructive pulmonary tuberculosis were defined on the basis of immunologic studies.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  3. 03HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In patients with destructive pulmonary tuberculosis, the thymalin and chemotherapy regimen showed a more evident normalizing influence on immune system recovery.

    In plain wordsIn patients with destructive lung tuberculosis, the thymalin and chemotherapy regimen showed greater normalization of immune system recovery.

    Peptide
    Thymalin
    Outcome
    IncreaseImmune system recovery
    Study

    n = 60

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Besides, more evident normalizing influence of the proposed option of therapy on the recovery of the immune system links is noted.
    1 context sentence
    Summary · context
    The criteria of differential administration of thymalin in the combined management of patients with destructive pulmonary tuberculosis were defined on the basis of immunologic studies.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.